IO Biotech, Inc. (IOBT) Misses Q2 EPS by 3c

IO Biotech, Inc. (NASDAQ: IOBT) reported Q2 EPS of ($0.40), $0.03 worse than the analyst estimate of ($0.37).

For earnings history and earnings-related data on IO Biotech, Inc. (IOBT) click here.

You May Also Be Interested In

• Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
• Israel said to eye US listing for major defense firms
• Doncasters Group IPO expected to price at top of range